136 related articles for article (PubMed ID: 35681118)
21. Effect of EphA7 Silencing on Proliferation, Invasion and Apoptosis in Human Laryngeal Cancer Cell Lines Hep-2 and AMC-HN-8.
Xiang C; Lv Y; Wei Y; Wei J; Miao S; Mao X; Gu X; Song K; Jia S
Cell Physiol Biochem; 2015; 36(2):435-45. PubMed ID: 25968442
[TBL] [Abstract][Full Text] [Related]
22. [Correlation between Methylation of SALL3 and Cervical Cancer].
Zhao J; Wei X; Yang T; Zhao MY; Pei ML; Yang XF
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Oct; 41(5):609-614. PubMed ID: 31699190
[TBL] [Abstract][Full Text] [Related]
23. High-risk HPV infection modulates the promoter hypermethylation of APC, SFRP1, and PTEN in cervical cancer patients of North India.
Kadian LK; Yadav R; Nanda S; Gulshan G; Sharma S; Yadav C
Mol Biol Rep; 2020 Dec; 47(12):9725-9732. PubMed ID: 33230782
[TBL] [Abstract][Full Text] [Related]
24. Up-regulation of expression and lack of 5' CpG island hypermethylation of p16 INK4a in HPV-positive cervical carcinomas.
Ivanova TA; Golovina DA; Zavalishina LE; Volgareva GM; Katargin AN; Andreeva YY; Frank GA; Kisseljov FL; Kisseljova NP
BMC Cancer; 2007 Mar; 7():47. PubMed ID: 17359536
[TBL] [Abstract][Full Text] [Related]
25. Aberrant promoter methylation and silencing of RASSF2A gene in cervical cancer.
Zhang X; Ma Y; Wu Y; Lin L; Ma X; Zhang Y
J Obstet Gynaecol Res; 2014 May; 40(5):1375-81. PubMed ID: 24605823
[TBL] [Abstract][Full Text] [Related]
26. Aberrant single-minded homolog 1 methylation as a potential biomarker for cervical cancer.
Kim HJ; Kim CY; Jin J; Bae MK; Kim YH; Ju W; Kim YH; Kim SC
Diagn Cytopathol; 2018 Jan; 46(1):15-21. PubMed ID: 29063719
[TBL] [Abstract][Full Text] [Related]
27. The role of ADCYAP1, adenylate cyclase activating polypeptide 1, as a methylation biomarker for the early detection of cervical cancer.
Jung S; Yi L; Jeong D; Kim J; An S; Oh TJ; Kim CH; Kim CJ; Yang Y; Kim KI; Lim JS; Lee MS
Oncol Rep; 2011 Jan; 25(1):245-52. PubMed ID: 21109983
[TBL] [Abstract][Full Text] [Related]
28. IGSF4 promoter methylation and expression silencing in human cervical cancer.
Li J; Zhang Z; Bidder M; Funk MC; Nguyen L; Goodfellow PJ; Rader JS
Gynecol Oncol; 2005 Jan; 96(1):150-8. PubMed ID: 15589594
[TBL] [Abstract][Full Text] [Related]
29. DNA methylation in serum and tumors of cervical cancer patients.
Widschwendter A; Müller HM; Fiegl H; Ivarsson L; Wiedemair A; Müller-Holzner E; Goebel G; Marth C; Widschwendter M
Clin Cancer Res; 2004 Jan; 10(2):565-71. PubMed ID: 14760078
[TBL] [Abstract][Full Text] [Related]
30. Interplay between promoter methylation and chromosomal loss in gene silencing at 3p11-p14 in cervical cancer.
Lando M; Fjeldbo CS; Wilting SM; C Snoek B; Aarnes EK; Forsberg MF; Kristensen GB; Steenbergen RD; Lyng H
Epigenetics; 2015; 10(10):970-80. PubMed ID: 26291246
[TBL] [Abstract][Full Text] [Related]
31. Associations of MGMT promoter hypermethylation with squamous intraepithelial lesion and cervical carcinoma: A meta-analysis.
Huang J; Luo JY; Tan HZ
PLoS One; 2019; 14(10):e0222772. PubMed ID: 31574102
[TBL] [Abstract][Full Text] [Related]
32. Correlation of promoter hypermethylation in hTERT, DAPK and MGMT genes with cervical oncogenesis progression.
Iliopoulos D; Oikonomou P; Messinis I; Tsezou A
Oncol Rep; 2009 Jul; 22(1):199-204. PubMed ID: 19513524
[TBL] [Abstract][Full Text] [Related]
33. hTERT promoter activity and CpG methylation in HPV-induced carcinogenesis.
de Wilde J; Kooter JM; Overmeer RM; Claassen-Kramer D; Meijer CJ; Snijders PJ; Steenbergen RD
BMC Cancer; 2010 Jun; 10():271. PubMed ID: 20534141
[TBL] [Abstract][Full Text] [Related]
34. Aberrant promoter methylation and loss of suppressor of cytokine signalling-1 gene expression in the development of uterine cervical carcinogenesis.
Sobti RC; Singh N; Hussain S; Suri V; Nijhawan R; Bharti AC; Bharadwaj M; Das BC
Cell Oncol (Dordr); 2011 Dec; 34(6):533-43. PubMed ID: 21935712
[TBL] [Abstract][Full Text] [Related]
35. DNA methylation and carcinogenesis of PRDM5 in cervical cancer.
Cheng HY; Chen XW; Cheng L; Liu YD; Lou G
J Cancer Res Clin Oncol; 2010 Dec; 136(12):1821-5. PubMed ID: 20213097
[TBL] [Abstract][Full Text] [Related]
36. Promoter methylation of SEPT9 as a potential biomarker for early detection of cervical cancer and its overexpression predicts radioresistance.
Jiao X; Zhang S; Jiao J; Zhang T; Qu W; Muloye GM; Kong B; Zhang Q; Cui B
Clin Epigenetics; 2019 Aug; 11(1):120. PubMed ID: 31426855
[TBL] [Abstract][Full Text] [Related]
37. Methylomics analysis identifies epigenetically silenced genes and implies an activation of β-catenin signaling in cervical cancer.
Chen YC; Huang RL; Huang YK; Liao YP; Su PH; Wang HC; Chang CC; Lin YW; Yu MH; Chu TY; Lai HC
Int J Cancer; 2014 Jul; 135(1):117-27. PubMed ID: 24310984
[TBL] [Abstract][Full Text] [Related]
38. Promoter Methylation and Relative mRNA Expression of the p16 Gene in Cervical Cancer in North Indians.
Gupta A; Ahmad MK; Mahndi AA; Singh R; Pradeep Y
Asian Pac J Cancer Prev; 2016; 17(8):4149-54. PubMed ID: 27644676
[TBL] [Abstract][Full Text] [Related]
39. Detecting cervical cancer by quantitative promoter hypermethylation assay on cervical scrapings: a feasibility study.
Reesink-Peters N; Wisman GB; Jéronimo C; Tokumaru CY; Cohen Y; Dong SM; Klip HG; Buikema HJ; Suurmeijer AJ; Hollema H; Boezen HM; Sidransky D; van der Zee AG
Mol Cancer Res; 2004 May; 2(5):289-95. PubMed ID: 15192122
[TBL] [Abstract][Full Text] [Related]
40. DNA methylation of the RIZ1 tumor suppressor gene plays an important role in the tumorigenesis of cervical cancer.
Cheng HY; Gao Y; Lou G
Eur J Med Res; 2010 Jan; 15(1):20-4. PubMed ID: 20159667
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
